The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Irbesartan Market Research Report 2024
Synopsis
Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with hydrochlorothiazide for patients not well controlled or not expected to be well controlled on monotherapy.
The global Irbesartan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Irbesartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Irbesartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Irbesartan include Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Irbesartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irbesartan.
Report Scope
The Irbesartan market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irbesartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irbesartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
BMS
Sumitomo Dainippon Pharma
Novartis
Shionogi
Hanall
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Verdant Life Sciences
Angita Pharma
Auro Pharma
Avanstra
Zhuhai Rundu Pharma
Xiansheng Pharmaceutical
CTTQ
Tianjin Huairen Pharmaceutical
Jiangsu Wangao Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Ainuo Pharmaceutical
Yuanhe Pharmaceutical
Segment by Type
Combination Drugs
Prescribed Drugs
Segment by Application
Hyperlipidemia
High Blood Pressure
Heart Failure
Kidney Disease
Fibrous Fibrillation
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irbesartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irbesartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Irbesartan is an angiotensin receptor blocker (ARB) indicated to treat hypertension or diabetic nephropathy. It can also be used as part of a combination product with hydrochlorothiazide for patients not well controlled or not expected to be well controlled on monotherapy.
The global Irbesartan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Irbesartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Irbesartan is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Irbesartan include Teva, Sanofi, BMS, Sumitomo Dainippon Pharma, Novartis, Shionogi, Hanall, Taj Pharmaceuticals and Apotex, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Irbesartan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irbesartan.
Report Scope
The Irbesartan market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irbesartan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Irbesartan manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sanofi
BMS
Sumitomo Dainippon Pharma
Novartis
Shionogi
Hanall
Taj Pharmaceuticals
Apotex
Jiangsu Hengrui Medicine
Verdant Life Sciences
Angita Pharma
Auro Pharma
Avanstra
Zhuhai Rundu Pharma
Xiansheng Pharmaceutical
CTTQ
Tianjin Huairen Pharmaceutical
Jiangsu Wangao Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Ainuo Pharmaceutical
Yuanhe Pharmaceutical
Segment by Type
Combination Drugs
Prescribed Drugs
Segment by Application
Hyperlipidemia
High Blood Pressure
Heart Failure
Kidney Disease
Fibrous Fibrillation
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Irbesartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Irbesartan in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Irbesartan Market Overview
1.1 Product Overview and Scope of Irbesartan
1.2 Irbesartan Segment by Type
1.2.1 Global Irbesartan Market Value Comparison by Type (2024-2030)
1.2.2 Combination Drugs
1.2.3 Prescribed Drugs
1.3 Irbesartan Segment by Application
1.3.1 Global Irbesartan Market Value by Application: (2024-2030)
1.3.2 Hyperlipidemia
1.3.3 High Blood Pressure
1.3.4 Heart Failure
1.3.5 Kidney Disease
1.3.6 Fibrous Fibrillation
1.3.7 Other
1.4 Global Irbesartan Market Size Estimates and Forecasts
1.4.1 Global Irbesartan Revenue 2019-2030
1.4.2 Global Irbesartan Sales 2019-2030
1.4.3 Global Irbesartan Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Irbesartan Market Competition by Manufacturers
2.1 Global Irbesartan Sales Market Share by Manufacturers (2019-2024)
2.2 Global Irbesartan Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Irbesartan Average Price by Manufacturers (2019-2024)
2.4 Global Irbesartan Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Irbesartan, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Irbesartan, Product Type & Application
2.7 Irbesartan Market Competitive Situation and Trends
2.7.1 Irbesartan Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Irbesartan Players Market Share by Revenue
2.7.3 Global Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Irbesartan Retrospective Market Scenario by Region
3.1 Global Irbesartan Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Irbesartan Global Irbesartan Sales by Region: 2019-2030
3.2.1 Global Irbesartan Sales by Region: 2019-2024
3.2.2 Global Irbesartan Sales by Region: 2025-2030
3.3 Global Irbesartan Global Irbesartan Revenue by Region: 2019-2030
3.3.1 Global Irbesartan Revenue by Region: 2019-2024
3.3.2 Global Irbesartan Revenue by Region: 2025-2030
3.4 North America Irbesartan Market Facts & Figures by Country
3.4.1 North America Irbesartan Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Irbesartan Sales by Country (2019-2030)
3.4.3 North America Irbesartan Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Irbesartan Market Facts & Figures by Country
3.5.1 Europe Irbesartan Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Irbesartan Sales by Country (2019-2030)
3.5.3 Europe Irbesartan Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Irbesartan Market Facts & Figures by Country
3.6.1 Asia Pacific Irbesartan Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Irbesartan Sales by Country (2019-2030)
3.6.3 Asia Pacific Irbesartan Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Irbesartan Market Facts & Figures by Country
3.7.1 Latin America Irbesartan Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Irbesartan Sales by Country (2019-2030)
3.7.3 Latin America Irbesartan Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Irbesartan Market Facts & Figures by Country
3.8.1 Middle East and Africa Irbesartan Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Irbesartan Sales by Country (2019-2030)
3.8.3 Middle East and Africa Irbesartan Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Irbesartan Sales by Type (2019-2030)
4.1.1 Global Irbesartan Sales by Type (2019-2024)
4.1.2 Global Irbesartan Sales by Type (2025-2030)
4.1.3 Global Irbesartan Sales Market Share by Type (2019-2030)
4.2 Global Irbesartan Revenue by Type (2019-2030)
4.2.1 Global Irbesartan Revenue by Type (2019-2024)
4.2.2 Global Irbesartan Revenue by Type (2025-2030)
4.2.3 Global Irbesartan Revenue Market Share by Type (2019-2030)
4.3 Global Irbesartan Price by Type (2019-2030)
5 Segment by Application
5.1 Global Irbesartan Sales by Application (2019-2030)
5.1.1 Global Irbesartan Sales by Application (2019-2024)
5.1.2 Global Irbesartan Sales by Application (2025-2030)
5.1.3 Global Irbesartan Sales Market Share by Application (2019-2030)
5.2 Global Irbesartan Revenue by Application (2019-2030)
5.2.1 Global Irbesartan Revenue by Application (2019-2024)
5.2.2 Global Irbesartan Revenue by Application (2025-2030)
5.2.3 Global Irbesartan Revenue Market Share by Application (2019-2030)
5.3 Global Irbesartan Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Irbesartan Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Irbesartan Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BMS
6.3.1 BMS Corporation Information
6.3.2 BMS Description and Business Overview
6.3.3 BMS Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BMS Irbesartan Product Portfolio
6.3.5 BMS Recent Developments/Updates
6.4 Sumitomo Dainippon Pharma
6.4.1 Sumitomo Dainippon Pharma Corporation Information
6.4.2 Sumitomo Dainippon Pharma Description and Business Overview
6.4.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sumitomo Dainippon Pharma Irbesartan Product Portfolio
6.4.5 Sumitomo Dainippon Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Irbesartan Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Shionogi
6.6.1 Shionogi Corporation Information
6.6.2 Shionogi Description and Business Overview
6.6.3 Shionogi Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shionogi Irbesartan Product Portfolio
6.6.5 Shionogi Recent Developments/Updates
6.7 Hanall
6.6.1 Hanall Corporation Information
6.6.2 Hanall Description and Business Overview
6.6.3 Hanall Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hanall Irbesartan Product Portfolio
6.7.5 Hanall Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Corporation Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taj Pharmaceuticals Irbesartan Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Apotex Irbesartan Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Hengrui Medicine Irbesartan Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Verdant Life Sciences
6.11.1 Verdant Life Sciences Corporation Information
6.11.2 Verdant Life Sciences Irbesartan Description and Business Overview
6.11.3 Verdant Life Sciences Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Verdant Life Sciences Irbesartan Product Portfolio
6.11.5 Verdant Life Sciences Recent Developments/Updates
6.12 Angita Pharma
6.12.1 Angita Pharma Corporation Information
6.12.2 Angita Pharma Irbesartan Description and Business Overview
6.12.3 Angita Pharma Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Angita Pharma Irbesartan Product Portfolio
6.12.5 Angita Pharma Recent Developments/Updates
6.13 Auro Pharma
6.13.1 Auro Pharma Corporation Information
6.13.2 Auro Pharma Irbesartan Description and Business Overview
6.13.3 Auro Pharma Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Auro Pharma Irbesartan Product Portfolio
6.13.5 Auro Pharma Recent Developments/Updates
6.14 Avanstra
6.14.1 Avanstra Corporation Information
6.14.2 Avanstra Irbesartan Description and Business Overview
6.14.3 Avanstra Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Avanstra Irbesartan Product Portfolio
6.14.5 Avanstra Recent Developments/Updates
6.15 Zhuhai Rundu Pharma
6.15.1 Zhuhai Rundu Pharma Corporation Information
6.15.2 Zhuhai Rundu Pharma Irbesartan Description and Business Overview
6.15.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zhuhai Rundu Pharma Irbesartan Product Portfolio
6.15.5 Zhuhai Rundu Pharma Recent Developments/Updates
6.16 Xiansheng Pharmaceutical
6.16.1 Xiansheng Pharmaceutical Corporation Information
6.16.2 Xiansheng Pharmaceutical Irbesartan Description and Business Overview
6.16.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Xiansheng Pharmaceutical Irbesartan Product Portfolio
6.16.5 Xiansheng Pharmaceutical Recent Developments/Updates
6.17 CTTQ
6.17.1 CTTQ Corporation Information
6.17.2 CTTQ Irbesartan Description and Business Overview
6.17.3 CTTQ Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.17.4 CTTQ Irbesartan Product Portfolio
6.17.5 CTTQ Recent Developments/Updates
6.18 Tianjin Huairen Pharmaceutical
6.18.1 Tianjin Huairen Pharmaceutical Corporation Information
6.18.2 Tianjin Huairen Pharmaceutical Irbesartan Description and Business Overview
6.18.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio
6.18.5 Tianjin Huairen Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Wangao Pharmaceutical
6.19.1 Jiangsu Wangao Pharmaceutical Corporation Information
6.19.2 Jiangsu Wangao Pharmaceutical Irbesartan Description and Business Overview
6.19.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio
6.19.5 Jiangsu Wangao Pharmaceutical Recent Developments/Updates
6.20 Zhejiang Huahai Pharmaceutical
6.20.1 Zhejiang Huahai Pharmaceutical Corporation Information
6.20.2 Zhejiang Huahai Pharmaceutical Irbesartan Description and Business Overview
6.20.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio
6.20.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Ainuo Pharmaceutical
6.21.1 Zhejiang Ainuo Pharmaceutical Corporation Information
6.21.2 Zhejiang Ainuo Pharmaceutical Irbesartan Description and Business Overview
6.21.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio
6.21.5 Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
6.22 Yuanhe Pharmaceutical
6.22.1 Yuanhe Pharmaceutical Corporation Information
6.22.2 Yuanhe Pharmaceutical Irbesartan Description and Business Overview
6.22.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Yuanhe Pharmaceutical Irbesartan Product Portfolio
6.22.5 Yuanhe Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Irbesartan Industry Chain Analysis
7.2 Irbesartan Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Irbesartan Production Mode & Process
7.4 Irbesartan Sales and Marketing
7.4.1 Irbesartan Sales Channels
7.4.2 Irbesartan Distributors
7.5 Irbesartan Customers
8 Irbesartan Market Dynamics
8.1 Irbesartan Industry Trends
8.2 Irbesartan Market Drivers
8.3 Irbesartan Market Challenges
8.4 Irbesartan Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Irbesartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Irbesartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Irbesartan Market Competitive Situation by Manufacturers in 2023
Table 4. Global Irbesartan Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Irbesartan Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Irbesartan Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Irbesartan Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Irbesartan Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Irbesartan, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Irbesartan, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Irbesartan, Product Type & Application
Table 12. Global Key Manufacturers of Irbesartan, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Irbesartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Irbesartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Irbesartan Sales by Region (2019-2024) & (KG)
Table 18. Global Irbesartan Sales Market Share by Region (2019-2024)
Table 19. Global Irbesartan Sales by Region (2025-2030) & (KG)
Table 20. Global Irbesartan Sales Market Share by Region (2025-2030)
Table 21. Global Irbesartan Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Irbesartan Revenue Market Share by Region (2019-2024)
Table 23. Global Irbesartan Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Irbesartan Revenue Market Share by Region (2025-2030)
Table 25. North America Irbesartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Irbesartan Sales by Country (2019-2024) & (KG)
Table 27. North America Irbesartan Sales by Country (2025-2030) & (KG)
Table 28. North America Irbesartan Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Irbesartan Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Irbesartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Irbesartan Sales by Country (2019-2024) & (KG)
Table 32. Europe Irbesartan Sales by Country (2025-2030) & (KG)
Table 33. Europe Irbesartan Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Irbesartan Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Irbesartan Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Irbesartan Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Irbesartan Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Irbesartan Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Irbesartan Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Irbesartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Irbesartan Sales by Country (2019-2024) & (KG)
Table 42. Latin America Irbesartan Sales by Country (2025-2030) & (KG)
Table 43. Latin America Irbesartan Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Irbesartan Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Irbesartan Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Irbesartan Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Irbesartan Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Irbesartan Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Irbesartan Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Irbesartan Sales (KG) by Type (2019-2024)
Table 51. Global Irbesartan Sales (KG) by Type (2025-2030)
Table 52. Global Irbesartan Sales Market Share by Type (2019-2024)
Table 53. Global Irbesartan Sales Market Share by Type (2025-2030)
Table 54. Global Irbesartan Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Irbesartan Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Irbesartan Revenue Market Share by Type (2019-2024)
Table 57. Global Irbesartan Revenue Market Share by Type (2025-2030)
Table 58. Global Irbesartan Price (US$/G) by Type (2019-2024)
Table 59. Global Irbesartan Price (US$/G) by Type (2025-2030)
Table 60. Global Irbesartan Sales (KG) by Application (2019-2024)
Table 61. Global Irbesartan Sales (KG) by Application (2025-2030)
Table 62. Global Irbesartan Sales Market Share by Application (2019-2024)
Table 63. Global Irbesartan Sales Market Share by Application (2025-2030)
Table 64. Global Irbesartan Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Irbesartan Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Irbesartan Revenue Market Share by Application (2019-2024)
Table 67. Global Irbesartan Revenue Market Share by Application (2025-2030)
Table 68. Global Irbesartan Price (US$/G) by Application (2019-2024)
Table 69. Global Irbesartan Price (US$/G) by Application (2025-2030)
Table 70. Teva Corporation Information
Table 71. Teva Description and Business Overview
Table 72. Teva Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Teva Irbesartan Product
Table 74. Teva Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Sanofi Irbesartan Product
Table 79. Sanofi Recent Developments/Updates
Table 80. BMS Corporation Information
Table 81. BMS Description and Business Overview
Table 82. BMS Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. BMS Irbesartan Product
Table 84. BMS Recent Developments/Updates
Table 85. Sumitomo Dainippon Pharma Corporation Information
Table 86. Sumitomo Dainippon Pharma Description and Business Overview
Table 87. Sumitomo Dainippon Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Sumitomo Dainippon Pharma Irbesartan Product
Table 89. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Novartis Irbesartan Product
Table 94. Novartis Recent Developments/Updates
Table 95. Shionogi Corporation Information
Table 96. Shionogi Description and Business Overview
Table 97. Shionogi Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Shionogi Irbesartan Product
Table 99. Shionogi Recent Developments/Updates
Table 100. Hanall Corporation Information
Table 101. Hanall Description and Business Overview
Table 102. Hanall Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Hanall Irbesartan Product
Table 104. Hanall Recent Developments/Updates
Table 105. Taj Pharmaceuticals Corporation Information
Table 106. Taj Pharmaceuticals Description and Business Overview
Table 107. Taj Pharmaceuticals Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Taj Pharmaceuticals Irbesartan Product
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Apotex Corporation Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Apotex Irbesartan Product
Table 114. Apotex Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Corporation Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Jiangsu Hengrui Medicine Irbesartan Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Verdant Life Sciences Corporation Information
Table 121. Verdant Life Sciences Description and Business Overview
Table 122. Verdant Life Sciences Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Verdant Life Sciences Irbesartan Product
Table 124. Verdant Life Sciences Recent Developments/Updates
Table 125. Angita Pharma Corporation Information
Table 126. Angita Pharma Description and Business Overview
Table 127. Angita Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Angita Pharma Irbesartan Product
Table 129. Angita Pharma Recent Developments/Updates
Table 130. Auro Pharma Corporation Information
Table 131. Auro Pharma Description and Business Overview
Table 132. Auro Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Auro Pharma Irbesartan Product
Table 134. Auro Pharma Recent Developments/Updates
Table 135. Avanstra Corporation Information
Table 136. Avanstra Description and Business Overview
Table 137. Avanstra Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Avanstra Irbesartan Product
Table 139. Avanstra Recent Developments/Updates
Table 140. Zhuhai Rundu Pharma Corporation Information
Table 141. Zhuhai Rundu Pharma Description and Business Overview
Table 142. Zhuhai Rundu Pharma Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Zhuhai Rundu Pharma Irbesartan Product
Table 144. Zhuhai Rundu Pharma Recent Developments/Updates
Table 145. Xiansheng Pharmaceutical Corporation Information
Table 146. Xiansheng Pharmaceutical Description and Business Overview
Table 147. Xiansheng Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Xiansheng Pharmaceutical Irbesartan Product
Table 149. Xiansheng Pharmaceutical Recent Developments/Updates
Table 150. CTTQ Corporation Information
Table 151. CTTQ Description and Business Overview
Table 152. CTTQ Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. CTTQ Irbesartan Product
Table 154. CTTQ Recent Developments/Updates
Table 155. Tianjin Huairen Pharmaceutical Corporation Information
Table 156. Tianjin Huairen Pharmaceutical Description and Business Overview
Table 157. Tianjin Huairen Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Tianjin Huairen Pharmaceutical Irbesartan Product
Table 159. Tianjin Huairen Pharmaceutical Recent Developments/Updates
Table 160. Jiangsu Wangao Pharmaceutical Corporation Information
Table 161. Jiangsu Wangao Pharmaceutical Description and Business Overview
Table 162. Jiangsu Wangao Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 163. Jiangsu Wangao Pharmaceutical Irbesartan Product
Table 164. Jiangsu Wangao Pharmaceutical Recent Developments/Updates
Table 165. Zhejiang Huahai Pharmaceutical Corporation Information
Table 166. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 167. Zhejiang Huahai Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 168. Zhejiang Huahai Pharmaceutical Irbesartan Product
Table 169. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Ainuo Pharmaceutical Corporation Information
Table 171. Zhejiang Ainuo Pharmaceutical Description and Business Overview
Table 172. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 173. Zhejiang Ainuo Pharmaceutical Irbesartan Product
Table 174. Zhejiang Ainuo Pharmaceutical Recent Developments/Updates
Table 175. Yuanhe Pharmaceutical Corporation Information
Table 176. Yuanhe Pharmaceutical Description and Business Overview
Table 177. Yuanhe Pharmaceutical Irbesartan Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 178. Yuanhe Pharmaceutical Irbesartan Product
Table 179. Yuanhe Pharmaceutical Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Irbesartan Distributors List
Table 183. Irbesartan Customers List
Table 184. Irbesartan Market Trends
Table 185. Irbesartan Market Drivers
Table 186. Irbesartan Market Challenges
Table 187. Irbesartan Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Irbesartan
Figure 2. Global Irbesartan Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Irbesartan Market Share by Type in 2023 & 2030
Figure 4. Combination Drugs Product Picture
Figure 5. Prescribed Drugs Product Picture
Figure 6. Global Irbesartan Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Irbesartan Market Share by Application in 2023 & 2030
Figure 8. Hyperlipidemia
Figure 9. High Blood Pressure
Figure 10. Heart Failure
Figure 11. Kidney Disease
Figure 12. Fibrous Fibrillation
Figure 13. Other
Figure 14. Global Irbesartan Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Irbesartan Market Size (2019-2030) & (US$ Million)
Figure 16. Global Irbesartan Sales (2019-2030) & (KG)
Figure 17. Global Irbesartan Average Price (US$/G) & (2019-2030)
Figure 18. Irbesartan Report Years Considered
Figure 19. Irbesartan Sales Share by Manufacturers in 2023
Figure 20. Global Irbesartan Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Irbesartan Players: Market Share by Revenue in 2023
Figure 22. Irbesartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Irbesartan Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Irbesartan Sales Market Share by Country (2019-2030)
Figure 25. North America Irbesartan Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Irbesartan Sales Market Share by Country (2019-2030)
Figure 29. Europe Irbesartan Revenue Market Share by Country (2019-2030)
Figure 30. Germany Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Irbesartan Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Irbesartan Revenue Market Share by Region (2019-2030)
Figure 37. China Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Irbesartan Sales Market Share by Country (2019-2030)
Figure 48. Latin America Irbesartan Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Irbesartan Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Irbesartan Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Irbesartan Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Irbesartan by Type (2019-2030)
Figure 58. Global Revenue Market Share of Irbesartan by Type (2019-2030)
Figure 59. Global Irbesartan Price (US$/G) by Type (2019-2030)
Figure 60. Global Sales Market Share of Irbesartan by Application (2019-2030)
Figure 61. Global Revenue Market Share of Irbesartan by Application (2019-2030)
Figure 62. Global Irbesartan Price (US$/G) by Application (2019-2030)
Figure 63. Irbesartan Value Chain
Figure 64. Irbesartan Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
